BMEDiShares Health Innovation Active ETF

Grow my money5y track recordRanked #2,184 of 2,960 in this goal

Seeks to maximize total return.

By BlackRock · Launched 2020

Annual Cost

0.55%

#2,811 of 5,562 · average

Fund Size

$10M

#4,737 of 5,562 · small

Return (1Y)Goal

+17.6%

Track Record

5 years

#2,201 of 5,562 · seasoned

Performance

Total-return NAV · USD

Growth of $10,000

$11,764+17.6%

Total-return NAV, USD. Net of fund fees, before tax.

Classification

How Beacon categorizes this fund

Asset class

Equity

Region

North america

Cap

Multi cap

Strategy

Active selection

Sector

Health care

Focus

General Innovation

What it actually holds

By weight

Concentration

Top 10 holdings = 29.3% of fund✓ well diversified

BlackRock Funds III

4.1%

Johnson & Johnson

3.6%

Gilead Sciences Inc

3.1%

Exact Sciences Corp

2.9%

Medtronic PLC

2.9%

Guardant Health Inc

2.7%

Merck & Co Inc

2.7%

Roche Holding AG

2.6%

Edwards Lifesciences Corp

2.5%

IQVIA Holdings Inc

2.2%

Asset allocation

Stocks

94.9%

Cash

5.1%

By sector

Healthcare

100.0%

Risk profile

Last 12 months · Sharpe & Sortino need 3+ years

Volatility (1Y)

15.4%Moderate

Year-on-year price swings

Max drawdown

-36.4%Severe

Worst peak-to-trough loss

Sharpe (3Y)

0.17Below average

Sortino (3Y)

0.23Moderate downside risk

Where to buy

Listing

Exchange: NYSE Arca

Full fund details

Objective: Seeks to maximize total return.
Strategy: Invests primarily in equity securities of companies in the health sciences group, targeting innovative and emerging firms. Derivatives count toward the 80% policy if they provide exposure to these securities.
Inception date: September 29, 2020
Fund family: BlackRock